Emjard L 5/25mg (14 Tablet / Pack)
High-strength prescription combination tablet indicated for advanced type 2 diabetes control.
Emjard L 5/25mg Tablets are a high-strength oral prescription combination medication indicated for optimizing blood sugar profiles in type 2 diabetes. The formulation effectively prevents renal glucose reabsorption while protecting incretin hormones from rapid enzyme degradation. This robust metabolic support significantly lowers HbA1c percentages and provides established cardiovascular defensive benefits in high-risk patients.
Purpose
Used to optimize blood sugar levels and enhance cardiovascular safety profiles.
Ingredients
Linagliptin 5mg, Empagliflozin 25mg
Warnings
Assess and correct systemic volume depletion before initializing this treatment. Monitor for severe, debilitating joint pain during the course of therapy. Discontinue therapy prior to major surgeries to minimize ketoacidosis risks. Not recommended for use during the second and third trimesters of pregnancy.
Side Effects
Genital yeast infections Urinary tract discomfort Increased volume of urination Mild upper respiratory irritation
Storage Instructions
Store below 30°C in original blister packaging away from moisture.
| Status | Active |
Related Products
Vesun Sunblock Cream Spf60 (60g)
Venlay Skin Brightening Cream (100g)
Venlay Brightening Face Wash (100ml)
Sylic A Serum (20ml)
Sylic A Face Wash (100ml)
Rucid syrup (120ml)
Rivia Anti Dandruff Shampoo (120ml)
